Market Tracker

11/21 6:05pm ET

Repros Therapeutics Inc (NASDAQ:RPRX)

8.79
Data as of Nov 21
 -0.19 / -2.12%
Today’s Change
5.92
Today|||52-Week Range
22.57
-51.97%
Year-to-Date

Today’s Trading

Previous close8.98
Today’s open9.14
Day’s range8.77 - 9.18
Volume699,537
Average volume (3 months)1,462,530
Market cap$213.4M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-12.71%
Earnings growth (this year)-4.26%
Earnings growth (next 5 years)-21.91%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.68

Competitors

 Today’s
change
Today’s
% change
IDRAIdera Pharmaceutical...+0.01+0.40%
MRTXMirati Therapeutics ...+0.10+0.63%
CARACara Therapeutics In...-0.06-0.72%
CCXIChemoCentryx Inc-0.16-3.29%
Data as of 4:00pm ET, 11/21/2014

Financials

Last reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$0.00
Annual profit (last year)-$27.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts